Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)

Krista A. Goulding, Adam Schwartz, Steven J. Hattrup, R Randall, Donald Lee, Damian M. Rispoli, Daniel M. Lerman, Christopher Beauchamp

Research output: Contribution to journalComment/debate

Abstract

A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.

Original languageEnglish (US)
Number of pages1
JournalClinical Orthopaedics and Related Research
Volume475
Issue number6
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

Fingerprint

Osseointegration
Disclosure
Upper Extremity
Arthroplasty
Orthopedics
Databases
Bone and Bones
Research
Neoplasms
Financial Statements
National Center for Advancing Translational Sciences (U.S.)

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Erratum to : Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0). / Goulding, Krista A.; Schwartz, Adam; Hattrup, Steven J.; Randall, R; Lee, Donald; Rispoli, Damian M.; Lerman, Daniel M.; Beauchamp, Christopher.

In: Clinical Orthopaedics and Related Research, Vol. 475, No. 6, 01.06.2017.

Research output: Contribution to journalComment/debate

@article{58ed3734c1ee48e3a1497714720d9e0b,
title = "Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research{\circledR}, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)",
abstract = "A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.",
author = "Goulding, {Krista A.} and Adam Schwartz and Hattrup, {Steven J.} and R Randall and Donald Lee and Rispoli, {Damian M.} and Lerman, {Daniel M.} and Christopher Beauchamp",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s11999-017-5299-4",
language = "English (US)",
volume = "475",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Erratum to

T2 - Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)

AU - Goulding, Krista A.

AU - Schwartz, Adam

AU - Hattrup, Steven J.

AU - Randall, R

AU - Lee, Donald

AU - Rispoli, Damian M.

AU - Lerman, Daniel M.

AU - Beauchamp, Christopher

PY - 2017/6/1

Y1 - 2017/6/1

N2 - A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.

AB - A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.

UR - http://www.scopus.com/inward/record.url?scp=85014535373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014535373&partnerID=8YFLogxK

U2 - 10.1007/s11999-017-5299-4

DO - 10.1007/s11999-017-5299-4

M3 - Comment/debate

C2 - 28265883

AN - SCOPUS:85014535373

VL - 475

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 6

ER -